Mot de passe
Afficher le mot de passe
Mot de passe oublié ?
Devenir membre gratuitement
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Cotations dynamiques 


SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur ALLERGAN, INC.
2017Mylan defends chairman to ISS ahead of June 22 investor vote
2017ALLERGAN : to Present New Data on Chronic Migraine at the American Headache Society Meetin..
2017U.S. state, local government lawsuits over opioids face uphill battle
2017ALLERGAN : to Present Data from its Anti-Infectives Portfolio at ASM Microbe 2017 in New O..
2017ALLERGAN : Kristin Chenoweth Kicks Off 'Less Red, More You' Campaign To Launch RHOFADE&tra..
2017ALLERGAN : Eyepowerment™ Campaign Releases Survey Revealing the Importance of Eye La..
2017Several top fund managers trim Allergan stakes in first quarter
2017CARL ICAHN : Icahn takes new 19.8 million share stake in Conduent in first quarter
2017High-profile Snap stakeholders revealed in filings
2017High-profile Snap stakeholders revealed in filings
2017AKTIEN NEW YORK : Dow schwächelt erneut - Einzelhandel im Fokus
2017AKTIEN NEW YORK AUSBLICK : Erneut moderate Verluste - Einzelhandel im Fokus
2017WDH/AKTIEN NEW YORK : Dow schwächer - Enttäuschende Unternehmenszahlen
2017AKTIEN NEW YORK AUSBLICK : Dow leicht im Minus - Quartalszahlen-Desaster bei Snap
2017AKTIEN NEW YORK : Leichte Einbußen im frühen Handel
2017AKTIEN NEW YORK : Leichte Einbußen im frühen Handel
2017AKTIEN NEW YORK AUSBLICK : Leichte Verluste vor Reden von Fed-Mitgliedern
2017Allergan posts loss as it writes down Teva holdings
2017Allergan posts loss as it writes down Teva holdings
2017Sanofi pegs U.S. drug price rises to below healthcare inflation
2017AKTIEN NEW YORK : Moderates Plus vor Reden von Fed-Mitgliedern
2017AKTIEN NEW YORK AUSBLICK : Moderates Plus vor Reden von Fed-Mitgliedern
2017ALLERGAN : to Present New Data at the 2017 American College of Obstetricians and Gynecolog..
2017ALLERGAN : and Ironwood Launch Campaign Designed to Empower the Nearly 64 Million American..
2017ALLERGAN : Launches Frames of Mind, Encouraging People Living with Migraine to Share Commo..
2017ALLERGAN : Teams Up With Media Mogul Wendy Williams to Debut the Patient Empowerment Campa..
2017ALLERGAN : Announces Availability of RESTASIS MULTIDOSE™ (Cyclosporine Ophthalmic Em..
2017ALLERGAN : JUVÉDERM VOLLURE™ XC Approved by U.S. FDA for Correction of Facial Wrinkl..
2017ALLERGAN : New Survey Reveals Impact Of Double Chin On Self-Perception And Behavior
2017ALLERGAN : New Eyepowerment™ Campaign Urges The Up To 33 Million Americans Suffering..
2017HINTERGRUND-Warum Mega-Deals wie Kraft/Unilever platzen
2017Collapse of Kraft-Unilever tie-up extends run of failed mega-deals
2017Allergan to buy fat-fighter Zeltiq Aesthetics for $2.48 billion
2017Stada to hold takeover talks with rival suitors Cinven and Advent
2017ALLERGAN : Botox-Konzern kauft Fettzellen-Entferner Zeltiq für 2,5 Mrd Dollar
2017Botox-Hersteller Allergan will mit Milliarden-Zukauf Ästhetik-Geschäft ausbauen
2017Botox-Hersteller Allergan will mit Milliarden-Zukauf Ästhetik-Geschäft ausbauen
2017Allergan says U.S. tax reform unlikely in 2017, sees strong year
2017ALLERGAN : Launches See America(SM), a Bold Initiative Furthering the Fight Against Preven..
2017ALLERGAN : Launches Juvéderm® Volite - an Innovative Injectable Treatment Designed to Impr..
2017ALLERGAN : U.S. Food and Drug Administration Approves 72 mcg Dose of LINZESS® (linaclotide..
2017U.S. reaches settlement with Endo on pay-for-delay charges
2017ALLERGAN : Announces FDA Approval Of RHOFADE™ (Oxymetazoline Hydrochloride) Cream, 1..
2017Allergan to pay $15 million over failing to disclose merger talks
2017ALLERGAN : and Gedeon Richter Announce Positive Phase III Results for Ulipristal Acetate 5..
2017Pharma company executives debate drug pricing increases
2016ALLERGAN : Pharmafirma Allergan setzt Einkaufstour mit Milliardenzukauf fort
2016Actavis UK raised drug prices 12,000 percent, watchdog finds
2016U.S. states sue Mylan, Teva, others for fixing drug prices
2016Pharma execs weigh in on possible changes under Trump
2016Lilly's drug for Alzheimer's fails big trial; shares drop
2016ALLERGAN : Announces Partnership with Amy Dixon, Elite Paratriathlete, to Improve Patient-..
2016Teva trims 2016 outlook on drug launch delays
2016ALLERGAN : Announces Launch of TAYTULLA™ (Norethindrone Acetate and Ethinyl Estradio..
2016Drugmakers under fire for possible U.S. price fixing
2016Allergan CEO takes blame for big miss on quarterly earnings
2016ALLERGAN : Introduces RESTASIS MULTIDOSE™ (Cyclosporine Ophthalmic Emulsion) 0.05%, ..
2016ALLERGAN : Announces Changes to Board Leadership
2016ALLERGAN : JUVÉDERM VOLBELLA® XC Now Available To Doctors And Patients In The U.S.
2016ALLERGAN : Demonstrates Ongoing Commitment to Irritable Bowel Syndrome (IBS) with Developm..
2016ALLERGAN : Demonstrates Continued Commitment to Irritable Bowel Syndrome with Diarrhea Man..
2016U.S. targets corporate tax-reduction strategy with new regulation
2016Teva to sell Allergan's generics business in UK, Ireland for $769 million
2016AstraZeneca licenses respiratory drug to Insmed
2016Pfizer entscheidet sich gegen Aufspaltung in zwei Unternehmen
2016ALLERGAN : Acquires Akarna Therapeutics Adding to its Strong Development Program and Commi..
2016Allergan pays top dollar for 'stepping stones' from neurology to dermatology
2016Allergan kauft Fettleber-Spezialisten Tobira für Milliardensumme
2016ALLERGAN : Acquires Gene Therapy Company RetroSense Therapeutics Adding First-In-Class Tec..
2016ALLERGAN : and Adamas Announce Settlement with Amneal Related to NAMZARIC® Patent Litigati..
2016ALLERGAN : Bayer exploring sale of dermatology business - Bloomberg
2016Allergan vows limited price hikes, says 'outliers' deter research
2016U.S. slams EU, but Apple tax demand first issued in Washington
1  2  3  4  5  6  7  8  9Suiv.